ICB-USP | Instituto de Ciências Biomédicas
Av. Prof. Lineu Prestes, 1730 – Butantã – São Paulo/SP – CEP 05508-000. Instituição de ensino, pesquisa e extensão. Possui 2 cursos graduação, 6 programas de pós-graduação, além de …
ICB-USP | Instituto de Ciências Biomédicas
O ICB recomenda a observação da DORA em todos seus processos seletivos. Pesquisa do ICB-USP identifica relação entre falhas respiratórias e sono e aponta estimulação cerebral seletiva …
Home Page - NOSC Lab
The Laboratory of Transplantation Immunobiology (L.I.T) was created in August 2005 within the Department of Immunology, at the Institute of Biomedical Sciences IV, at the University of Sao …
Cancer Commun：免疫检查点抑制剂治疗结直肠癌的疗效和毒性：真实世界研究 …
免疫检查点阻断 (ICB)已被证实对DNA错配修复缺陷 (dMMR)/微卫星高度不稳定 (MSI- H)的 CRC有效，但对没有错配修复缺陷 (pMMR)/微卫星稳定 (MSS) 的CRC无效。 但是，目前没有真实世 …
Integrated Continuous Biomanufacturing: Industrialization on the ...
Feb 7, 2019 · The ICB III conference brought together leading scientists and engineers from academia, industry and regulatory authorities that are actively engaged in continuous …
Cancer Cell最新综述：新辅助免疫检查点阻断疗法——推动癌症免疫疗法的机遇|Cancer|免疫疗法|Cell|ICB…
Sep 1, 2023 · icb在以高新抗原负荷为特征的错配修复缺陷（mmrd）的癌症患者中具有显著的临床活性，并且其在围手术期环境中在该亚组中的使用是密集临床研究的领域。
Nat Rev | 免疫检查点阻断疗法的建立和伊匹单抗被批准的十年 - 知乎
近期，免疫治疗的先驱者Alan J. Korman在Nature review drug discovery杂志上发表了一篇名为“The foundations of immune checkpoint blockade and the ipilimumab approval decennial”的文 …
Integrated Continuous Biomanufacturing IV | Proceedings
Leveraging Sanofi intensified ICB platform to enable early process development for a labile and hard-to-express molecule, Jiuyi Lu, Daryl Powers, Nathan Ostberg, Emily Davenport, Jason …
Cell重磅综述：免疫检查点阻断（ICB）应答、耐药、毒性的特点
Mar 15, 2022 · 近些年，免疫检查点阻断（immune checkpoint blockade，ICB）在肿瘤治疗中取得了重要进展。但是，仅部分患者对治疗有应答，部分应答时间不理想，部分因免疫相关不良反 …
ICB-USP | Imunologia
ICB IV (Av. Prof. Lineu Prestes , nº 1730 – Butantã – São Paulo/SP – CEP 05508-000)
- Some results have been removed